Evidence map›Paper›PMID 30531302›Full record

Observational studyJournal of acquired immune deficiency syndromes (1999)2019

Vulnerable Periods: Characterizing Patterns of Sexual Risk and Substance Use During Lapses in Adherence to HIV Pre-exposure Prophylaxis Among Men Who Have Sex With Men.

Tyler B Wray, Philip A Chan, Christopher W Kahler, Erik M Simpanen, Tao Liu, Kenneth H Mayer

Abstract readObservational Study
In one paragraph

Observational study in Journal of acquired immune deficiency syndromes (1999), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Tyler B WrayCenter for Alcohol and Addictions Studies, Brown University School of Public Health, Providence, RI.
Philip A ChanDepartment of Medicine, Alpert Medical School of Brown University, Providence, RI.
Christopher W KahlerCenter for Alcohol and Addictions Studies, Brown University School of Public Health, Providence, RI.
Erik M SimpanenCenter for Alcohol and Addictions Studies, Brown University School of Public Health, Providence, RI.
Tao LiuDepartment of Biostatistics, Center for Statistical Sciences, School of Public Health, Brown University, Providence, RI.
Kenneth H MayerBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Brown University · USBeth Israel Deaconess Medical Center · US

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI LARRY K BROWN · 1998 to 2026
$51.7M
Virology CoreP01AA019072 · NIAAA · BROWN UNIVERSITY · PI BECKER, SARA · 2010 to 2024
$19.7M
NIAAA NIH HHS L30 AA023336NIAAA NIH HHS P01 AA019072NIAID NIH HHS P30 AI042853
6 · The paper itself

Abstract

backgroundPre-exposure prophylaxis (PrEP) is highly efficacious, but some groups of men who have sex with men may have difficulty adhering to daily dosing. Prevention-effective adherence suggests that PrEP's efficacy depends on adherence at the time of HIV exposure; yet, few studies have examined how exposures (ie, high-risk sex) overlap with periods of consecutive missed PrEP doses. Substance use may also play a role in these vulnerable periods.

methodsWe used digital pill bottles to monitor the daily adherence of 40 PrEP-experienced patients recruited from an outpatient clinic in the Northeastern US over a six-month period. Participants also completed detailed online diaries every 2 weeks during this time that surveyed their sexual behavior and substance use each day.

resultsDaily adherence was high overall (M = 83.9%, SD = 18.0%), but 53% (N = 21) had a lapse of > 3 consecutive daily PrEP doses over 6 months. Participants' rate of engaging in high-risk condomless anal sex (CAS) did not differ across lapse days versus continuously adherent days. Alcohol use was not associated with engaging in CAS during a PrEP lapse. However, participants reported engaging in CAS significantly more often during a PrEP adherence lapse on days when they also used stimulant drugs.

conclusionsMen who have sex with men may have periodic difficulty adhering to PrEP at the specific times when they are at risk. Stimulant drug use could play an important role in increasing HIV risk specifically during adherence lapses.

Indexed as

Homosexuality, MaleMedication AdherencePre-Exposure ProphylaxisSubstance-Related DisordersUnsafe SexAnti-HIV AgentsHumansMaleRisk-TakingAnti-HIV Agents

Identifiers

PMID30531302
PMCPMC6534124
OpenAlexW2903569560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.